NSAID GASTROPATHIES: PREDICTING THEIR COURSE AND OUTCOMES
DOI: https://doi.org/10.29296/25877305-2018-05-04
Issue:
5
Year:
2018
The problem of NSAID gastropathy is becoming a greater sociomedical importance due to the wide and frequently uncontrolled use of nonsteroidal anti-inflammatory drugs and to the risk of serious gastrointestinal complications.
Keywords:
gastroenterology
nonsteroidal anti-inflammatory drugs (NSAID)
NSAID gastropathy
proton pump inhibitors
References:
- Barskova V.G. Chto nam daet izuchenie statistiki prodazh nesteroidnyh protivovospalitel'nyh preparatov v Rossijskoj Federatsii? // Sovremennaja revmatologija. – 2011; 5 (3): 68–73.
- Vpasjuk V.B. Lechenie oslozhnennoj jazvennoj bolezni dvenadtsatiperstnoj kishki: sovremennye tendentsii v terapevticheskoj i hirurgicheskoj praktike // Sovremennaja meditsina. – 2010. URL: http://www.medblog.com.ua/articles/diseases/2371
- Zolotarev V.A. Nozdrachev A.D. Kapsaitsin-chuvstvitel'nye afferenty bluzhdajuschego nerva // Ross. fiziol. zhurn. – 2001; 87 (2): 182–204.
- Ivashkin V.T., Sheptulin A.A., Branskaja E.K. i dr. Klinicheskie rekomendatsii po diagnostike i lecheniju erozivno-jazvennyh porazhenij zheludka i dvenadtsatiperstnoj kishki, vyzvannyh nesteroidnymi protivovospalitel'nymi preparatami. Klinicheskie rekomendatsii / M., 2014.
- Karateev A.E. i dr. Klinicheskie rekomendatsii «Ratsional'noe primenenie nesteroidnyh protivovospalitel'nyh preparatov (NPVP) v klinicheskoj praktike» // Sovremennaja revmatologija. – 2015; 9 (1): 4–23.
- Karateev A.E., Uspenskij Ju.P., Pahomova I.G. i dr. Kombinirovannoe lechenie jazv zheludka, indutsirovannyh nesteroidnymi protivovospalitel'nymi preparatami. Rezul'taty 4-nedel'nogo otkrytogo kontroliruemogo issledovanija po otsenke effektivnosti kombinatsii ingibitora protonnoj pompy i vismuta trikalija ditsitrata // Ter. arh. – 2009; 81 (6): 62–6.
- Nasonov E.L., Karateev A.E. Primenenie nesteroidnyh protivovospalitel'nyh preparatov. Klinicheskie rekomendatsii // RMZh. – 2006; 25: 1769.
- Nasonov E.L., Ivashkin V.T., Jahno N.N. i dr. Ratsional'noe primenenie nesteroidnyh protivovospalitel'nyh preparatov po rezul'tatam soveschanija gruppy ekspertov // Nauchno-prakt. revmatol. – 2017; 55 (4): 452–6.
- Pahomova I.G. Novye vozmozhnosti v minimizatsii riska NPVP-indutsirovannyh gastropatij // RMZh. – 2014; 10: 772.
- Strachunskij L.S., Kozlov S.N. Nesteroidnye protivovospalitel'nye sredstva. Metodicheskoe posobie, 2017.
- Sheptulin A.A., Lapina T.L., Kajbysheva V.O. Novoe v izuchenii infektsii Helicobacter pylori i osnovnye polozhenija Soglasitel'nogo soveschanija Maastriht-V (2016) // Ros. zhurn. gastroenterol, gepatol. i koloproktol. – 2017; 27 (1): 35–43.
- Carli D., Pires R., Rohde S. et al. Peptic ulcer frequency differences related to N. pylori or aines // Arq. Gastroenterol. – 2015; 52 (1): 46–9.
- De Pretis G., Tasini E. Tollerabilita gastrica dell’antiinfiammatorio Amtolmetina Guacil: meta-analisi dei trials terapeutici / Med. Ther, 2002.
- Hawkey C., Wight N. NSAIDs and gastrointestinal complications / London: Life Science Communications, 2001; p. 1–56.
- Harry Hua-Xiang Xia et al. Reduction of Peptic Ulcer Disease and Helicobacter pylori Infection but Increase of Reflux Esophagitis in Western Sydney Between 1990 and 1998 // Dig. Dis. Sci. –2001; 46 (Issue 12): 2716–23.
- Ramakrishnan K., Salinas R. Peptic Ulcer Disease // Oklahoma Am. Fam. Physician. – 2007; 76 (7): 1005–12.
- Lanas A., Garcia-Rodriguez L., Arroyo M. et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations // Gut. – 2006; 55: 1731–8.
- Lanas A., Hunt R.. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies // Ann. Med. – 2006; 38: 415–28.
- Lain L. Approaches to nonsteroidal anti-inflammatory drugs in the high-risk patients // Gastroenterology. – 2001; 2: 594–606.
- Lanas A., Garcia-Rodriguez L., Arroyo M. et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants // Clin. Gastroenterol. Hepatol. – 2015; 13 (5): 906–12.
- Lanas A., Tornero J., Zamorano J.. Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study // Ann. Rheum. Dis. – 2010; 69 (8): 1453–8.
- Lué A., Lanas A. Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits // World J. Gastroenterol. – 2016; 22 (48): 10477–81.
- Lyseng-Williamson K., Foster R. Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis // Pharmacoeconomics. – 2004; 22 (2): 107–32.
- Malfertheiner P., Megraud F., O'Morain C. et al. European Helicobacter Study Group Management of Helicobacter pylori infection--the Maastricht IV // J. Florence Consensus Report. Gut. – 2012; 61 (5): 646–64.
- Mearin F., Ponce J. Potent acid inhibition: summary of the evidence and clinical application // Drugs. – 2005; 65 (Suppl. 1): 113–26.
- Montrone F., Santandrea S., Caruso I. et al. Amtolmetin guacyl versus piroxicam in patients with osteoarthritis // J. Int. Med. Res. – 2000; 28 (2): 91–100.
- Rostom A., Moayyedi P., Hunt R. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks // Aliment. Pharmacol. Ther. – 2009; 29: 481–96.
- Shaheen N., Hansen R., Morgan D. et al. The burden of gastrointestinal and liver diseases // Am. J. Gastroenterol. – 2006; 101: 2128–38.
- Sostres C., Jerusalen C., Lanas A. Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: Old question new insights // World J. Gastroenterol. – 2014; 20 (28): 9439–50.
- Straube S., Tramèr M., Moore R. et al. Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use // BMC Gastroenterol. – 2009; 9: 41.
- Tannenbaum H., Bombardier C., Davis P. et al. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference // J. Rheumatol. – 2006; 33: 140–57.
- Yakabi K., Kamiichi H., Ohno S. et al. Arteriosclerosis and gastroduodenal ulcer // Nippon Rinsho. – 2004; 62 (3): 525–31.